Veracyte reported $1.09B in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US $ 15.72M 18.72M
Agilent A:US $ 5122M 32M
Anika Therapeutics ANIK:US $ 285.79M 1.3M
Arrowhead Research ARWR:US $ 452.27M 79.71M
Biocept BIOC:US $ 37.03M 0.45M
Bruker BRKR:US $ 1017M 53.5M
Exact Sciences EXAS:US $ 3258.21M 129.43M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Illumina ILMN:US $ 10895M 155M
Immunogen IMGN:US $ 306.47M 19.12M
Intrexon XON:US $ 73.84M 33.51M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Laboratory Of America LH:US $ 10721.1M 447.7M
Ligand Pharmaceuticals LGND:US $ 793.19M 27.97M
Myriad Genetics MYGN:US $ 950.1M 17.7M
Rigel Pharmaceuticals RIGL:US $ 6.8M 23.58M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Siemens SIE:GR € 45536M 1467M
Sonic Healthcare SHL:AU $ 7.05B 668.87M
Thermo Fisher Scientific TMO:US $ 40956M 163M
Veracyte VCYT:US $ 1085.19M 11.32M
Waters WAT:US $ 374.94M 7.38M